Semaglutide injections, a glucagon-like peptide-1 (GLP-1) receptor agonist, are an effective tool for managing weight by regulating appetite and glucose metabolism
The reality of oral administration for musculoskeletal indications is straightforward: the peptide disperses through the digestive system before it reaches the injury site, and what arrives at a tendon or joint after that journey is a fraction of what a subcutaneous injection placed near the tissue delivers
Additionally, compared to the placebo, there was an adjusted improvement of 0.8% in the glycated hemoglobin (HbA1c) levels
USA Today reported that the program is a significant change because Medicare, the federal health program mainly for adults 65 and older, has been prohibited from covering weight loss medications, including GLP-1s
Planning ahead prevents last-minute delays that disrupt your weekly rhythm and compromise the steady-state benefits that make GLP-1 therapy effective
Detailed Instructions for Use can be found here